Ovarian Cancer

Dana Donofree, designer and founder of AnaOno Intimages, shares her own experience with cancer and discusses how to navigate sexual health and intimacy after surgery.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses PARP inhibitors and ways in which they might be combined with other cancer treatments.

Basser Center genetic counselor Danielle McKenna, MS, LCGC, explains what age at which at-risk individuals should consider testing for a BRCA mutation.

Basser Young Leadership Council member Katrina Wells, a BRCA mutation carrier, shares her personal story with how she is managing her ovarian cancer risk.

Penn Medicine's Ann L. Steiner, MD, an obstetrician-gynecologist and clinical professor, discusses what you need to know about surgical menopause.

Basser Young Leadership Council member Shannon Pulaski, an attorney, wife, and mother, writes about preventative care and the power of support.

Basser Young Leadership Council co-chair Suzanne Zuppello, a freelance writer in New York City, shares her personal story about her BRCA mutation and her decision to freeze her eggs.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses the differences between BRCA1 and BRCA2 mutations and explains how the varying risk factors could impact individuals and their families.

As part of an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses BRCA-related ovarian cancer risk and management options, such as recent research into fallopian tube removal.

In the first in an ongoing series of answers to common questions received by the Basser Center, Executive Director Susan Domchek, MD, discusses recent advancements in treatment options for BRCA-related cancers, such as drugs like PARP inhibitors.